Researchers are conducting phase-1 and phase-2 clinical trials on a China-made inhaled COVID-19 vaccine, a Chinese health official said, according to The Xinhua News Agency reports.
"After completing the collection of clinical-trial data, experts will study the safety and effectiveness of the inhaled vaccine, a modified version of an injectable adenovirus vector COVID-19 vaccine that has already hit the market", – said Shao Yiming, a researcher at the Chinese Center for Disease Control and Prevention, at a press conference.
The inhaled COVID-19 vaccine was jointly-developed by researchers from the Institute of Military Medicine under the Academy of Military Sciences and China's CanSino Biologics Inc.
"Inhaled or nasal-spray vaccines were selected as one of China's vaccine technologies to combat COVID-19 from the very beginning", – Shao added.
"Another nasal-spray COVID-19 vaccine, developed by Xiamen University, the University of Hong Kong and Beijing Wantai Biological Pharmacy, has completed phase-1 and phase-2 trials. Researchers are applying phase-3 clinical trials overseas, to further evaluate the efficacy of the vaccine", – according to Shao.
Who we are: About us, Contacts. How we write news and our principles: Editorial code. We did our best. If you found this valuable – please support us.
To request a correction, please send an email.